IRIS
SABA, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.454
EU - Europa 2.804
AS - Asia 2.297
SA - Sud America 514
AF - Africa 128
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.354
RU - Federazione Russa 1.028
SG - Singapore 883
VN - Vietnam 424
UA - Ucraina 397
BR - Brasile 383
CN - Cina 337
SE - Svezia 238
DE - Germania 203
TR - Turchia 203
IE - Irlanda 199
IT - Italia 183
HK - Hong Kong 166
DK - Danimarca 151
FR - Francia 141
FI - Finlandia 116
KR - Corea 81
GB - Regno Unito 70
CI - Costa d'Avorio 61
MX - Messico 48
AR - Argentina 46
BD - Bangladesh 36
CA - Canada 36
IN - India 34
IQ - Iraq 23
CO - Colombia 22
EC - Ecuador 22
ZA - Sudafrica 22
PL - Polonia 20
ID - Indonesia 18
JP - Giappone 18
MA - Marocco 18
PK - Pakistan 12
CL - Cile 11
NL - Olanda 11
PY - Paraguay 9
UZ - Uzbekistan 8
VE - Venezuela 8
BE - Belgio 7
RO - Romania 7
TN - Tunisia 7
AT - Austria 6
MY - Malesia 6
OM - Oman 6
PH - Filippine 6
UY - Uruguay 6
EG - Egitto 5
ES - Italia 5
LT - Lituania 5
SA - Arabia Saudita 5
BG - Bulgaria 4
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
PA - Panama 2
PS - Palestinian Territory 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
Totale 10.201
Salva come PNG Salva come JPEG
Città #
Ashburn 758
Singapore 540
Jacksonville 396
Chandler 350
Dallas 264
Fairfield 251
San Jose 239
Dublin 199
Boardman 183
Hong Kong 159
Ho Chi Minh City 145
Wilmington 143
New York 127
Woodbridge 120
Hanoi 113
Seattle 111
Moscow 110
Houston 106
Beijing 97
Lawrence 79
Princeton 79
San Mateo 79
Lauterbourg 70
Ann Arbor 69
Cambridge 69
Abidjan 61
Los Angeles 59
The Dalles 59
Hefei 57
Turin 44
Buffalo 39
São Paulo 39
Orem 30
Munich 29
Da Nang 23
Des Moines 20
Mexico City 20
San Diego 20
Santa Clara 20
Milan 19
Turku 19
Warsaw 19
Helsinki 18
London 18
Denver 17
Haiphong 15
Montreal 15
Tokyo 15
Johannesburg 13
Chennai 12
Chicago 12
Miano 12
Atlanta 11
Phoenix 11
Shanghai 11
Biên Hòa 10
Brasília 10
Izmir 10
Wuhan 10
Guayaquil 9
Rio de Janeiro 9
Stockholm 9
Buenos Aires 8
Can Tho 8
Council Bluffs 8
Guangzhou 8
Manchester 8
Nuremberg 8
Poplar 8
Tashkent 8
Baghdad 7
Campinas 7
Columbus 7
Falls Church 7
Jakarta 7
Wembley 7
Belo Horizonte 6
Bogotá 6
Brooklyn 6
Brussels 6
Dhaka 6
Montevideo 6
Mumbai 6
Norwalk 6
Querétaro 6
Amsterdam 5
Aracaju 5
Caracas 5
Curitiba 5
Kazan' 5
Kilburn 5
Maceió 5
Muscat 5
Nha Trang 5
Ottawa 5
Paris 5
Quận Bình Thạnh 5
Tân Tiến 5
Ankara 4
Boston 4
Totale 5.913
Salva come PNG Salva come JPEG
Nome #
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients 771
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 265
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 208
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 200
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 182
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 165
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 152
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 148
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 147
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 146
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 142
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 141
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 138
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 138
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 136
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 127
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 124
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 122
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 119
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 118
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 118
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 117
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 117
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 116
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 115
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 113
LL-37 protects rats against lethal gram-negative sepsis. 111
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 111
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 110
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 110
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 110
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 110
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 109
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 108
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 106
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 104
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 101
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 100
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 99
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 99
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 99
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 98
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 97
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 96
Mupirocin as prophylactic agent against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate Staphylococcus epidermidis vascular graft infection. 96
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 96
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 94
Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage in Euro-Collins and University of Wisconsin solutions 93
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 93
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 93
Potential therapeutic role of cationic peptides in three experimental models of septic shock 91
Valore prognostico dell'indice Apache II nell'impiego routinario preoperatorio in chirurgia generale maggiore 89
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 88
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 87
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 85
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 83
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 83
Temporin A alone and in combination with imipenem reduces lethality in mouse models of staphylococcal sepsis 81
Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model Infected with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides 81
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides 80
Single-dose intraperitoneal magainins improve survival in a gram-negative pathogens septic shock rat model. 80
A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging 78
RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections 76
Temporin A as prophylactic agent against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. 76
RNA III Inhibiting Peptide (RIP) inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus 75
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine models of staphylococcal sepsis 75
Interaction of antimicrobial peptide temporin L with lipopolisaccharide in vitro and in experimental rat models of Gram-negative septic shock. 72
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins 64
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc 59
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people 46
Totale 10.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.749
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.749
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/2022583 51 122 0 27 3 54 15 30 35 92 24 130
2022/20231.040 106 114 91 81 91 106 0 50 286 7 84 24
2023/2024518 109 12 22 88 89 122 5 5 3 4 13 46
2024/20251.462 171 100 93 82 63 95 163 69 260 55 140 171
2025/20264.416 210 371 329 425 371 268 596 404 1.010 289 44 99
Totale 10.294